Autologous
Exosomes

Autologous means it comes from you

ExoSmart uses plasma separated from your own blood. The practical distinction is its source: we prepare your own material rather than use a pre-filled exosome product from another biological source. It is more accurate to describe this as autologous than simply “more natural”.

More than isolated exosomes

Extracellular vesicles are small membrane-bound particles involved in communication between cells. Exosomes are one type. The ExoSmart preparation also contains platelets and soluble plasma components. It is not a purified vial of exosomes, and a laboratory particle count is not a count of confirmed exosomes.

Beyond platelet count: the broader plasma secretome

Traditional PRP preparation emphasises platelet concentration. ExoSmart adds a filtration step that concentrates platelet-rich and platelet-poor plasma together, bringing extracellular vesicles, growth factors and signalling proteins into a small injectable volume. This broader mixture is described as the autologous plasma secretome. PRP also contains plasma proteins and signalling components; the distinction is how the plasma fractions are processed and concentrated, rather than their complete absence from PRP.

A different preparation is not proof of superiority

There is a biological reason to study these components together. However, the available ExoSmart clinical observations do not establish better skin or hair outcomes than PRP or the products we previously used. We do not claim that one session replaces a fixed number of PRP sessions.

A blood sample is first processed to separate plasma. ExoSmart then concentrates platelet-rich plasma and platelet-poor plasma together through a hollow-fibre filter. Water and small substances pass through the membrane; retained components remain in a smaller volume.

The preparation is made for the same patient during the visit. The exact application method, treatment area and repeat-treatment plan are explained before consent. Face and scalp treatment should not be assumed to use an identical protocol.

ExoSmart is not a stem-cell transplant. The aim is to use the signalling components already present in plasma, not to introduce living donor stem cells.

Facial skin

The manufacturer reports small, uncontrolled studies of skin quality. One followed ten patients with ultrasound for a year after one treatment. Another assessed skin measurements at five weeks. These are early observations, not large comparative trials. They cannot establish a reliable result for every patient.

Hair and scalp

The reported ExoSmart hair series included ten patients followed for 90 days. Nine returned satisfaction forms. Satisfaction is useful feedback, but it is not proof of a defined increase in hair density or lasting regrowth.

We separate these device-specific observations from wider exosome research. Results from another product, laboratory model or application method do not automatically apply to your treatment.

Tell us about medicines, blood or bleeding conditions, current infection, pregnancy or breastfeeding, and any previous reaction to a blood draw or aesthetic treatment. Do not stop prescribed medicine without advice from your prescriber.

We explain the planned application method and give written aftercare for the treated area. Recovery depends on that method and any treatment performed alongside it; there is no universal “no downtime” promise.

Contact the clinic for increasing pain, spreading redness, unusual swelling or discharge. Seek urgent medical care if you have difficulty breathing or other severe symptoms.